204 related articles for article (PubMed ID: 23888376)
1. Advancement of human leukocyte antigen-partially matched related hematopoietic stem cell transplantation.
Mo X; Huang X
Front Med; 2013 Sep; 7(3):306-15. PubMed ID: 23888376
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem-cell transplantation from haploidentical donors using 'ex-vivo' T-cell depletion in pediatric patients with hematological malignancies: state of the art review.
González-Vicent M; Díaz Perez MA
Curr Opin Oncol; 2018 Nov; 30(6):396-401. PubMed ID: 30307414
[TBL] [Abstract][Full Text] [Related]
3. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT.
Marek A; Stern M; Chalandon Y; Ansari M; Ozsahin H; Güngör T; Gerber B; Kühne T; Passweg JR; Gratwohl A; Tichelli A; Seger R; Schanz U; Halter J; Stussi G;
Bone Marrow Transplant; 2014 Jan; 49(1):55-61. PubMed ID: 24037023
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
Anandi P; Tian X; Ito S; Muranski P; Chokshi PD; Watters N; Chawla U; Hensel N; Stroncek DF; Battiwalla M; Barrett AJ
Cytotherapy; 2017 Jun; 19(6):735-743. PubMed ID: 28395942
[TBL] [Abstract][Full Text] [Related]
5. Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.
Oshrine BR; Li Y; Teachey DT; Heimall J; Barrett DM; Bunin N
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1581-9. PubMed ID: 23939199
[TBL] [Abstract][Full Text] [Related]
6. Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors.
Redei I; Langston AA; Lonial S; Cherry JK; Allen AJ; Hamilton E; Jones M; Bartlett VM; Waller EK
Bone Marrow Transplant; 2002 Sep; 30(6):335-40. PubMed ID: 12235516
[TBL] [Abstract][Full Text] [Related]
7. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34
Kosuri S; Adrianzen Herrera D; Scordo M; Shah GL; Cho C; Devlin SM; Maloy MA; Nieves J; Borrill T; Carlow DC; Avecilla ST; Meagher RC; O'Reilly RJ; Papadopoulos EB; Jakubowski AA; Koehne G; Gyurkocza B; Castro-Malaspina H; Shaffer BC; Tamari R; Giralt SA; Perales MA
Biol Blood Marrow Transplant; 2017 Nov; 23(11):2004-2011. PubMed ID: 28733264
[TBL] [Abstract][Full Text] [Related]
9. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.
Dodero A; Carniti C; Raganato A; Vendramin A; Farina L; Spina F; Carlo-Stella C; Di Terlizzi S; Milanesi M; Longoni P; Gandola L; Lombardo C; Corradini P
Blood; 2009 May; 113(19):4771-9. PubMed ID: 19211934
[TBL] [Abstract][Full Text] [Related]
11. CD34
Barba P; Martino R; Zhou Q; Cho C; Castro-Malaspina H; Devlin S; Esquirol A; Giralt S; Jakubowski AA; Caballero D; Maloy M; Papadopoulos EB; Piñana JL; Fox ML; Márquez-Malaver FJ; Valcárcel D; Solano C; López-Corral L; Sierra J; Perales MA
Biol Blood Marrow Transplant; 2018 May; 24(5):964-972. PubMed ID: 29305194
[TBL] [Abstract][Full Text] [Related]
12. The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation.
Gasior M; Ferreras C; de Paz R; Bueno D; Mozo Y; Sisinni L; Canizales JT; González B; Olivas-Mazón R; Marcos A; Romero AB; Constanzo A; Mirones I; Fernández-Arroyo A; Balas A; Vicario JL; Escudero A; Yuste VJ; Pérez-Martínez A
Transfusion; 2021 May; 61(5):1505-1517. PubMed ID: 33713461
[TBL] [Abstract][Full Text] [Related]
13. "Ex-vivo" T-cell depletion in allogeneic hematopoietic stem cell transplantation: New clinical approaches for old challenges.
Diaz MA; Gasior M; Molina B; Pérez-Martínez A; González-Vicent M
Eur J Haematol; 2021 Jul; 107(1):38-47. PubMed ID: 33899960
[TBL] [Abstract][Full Text] [Related]
14. Immune reconstitution after haploidentical hematopoietic stem cell transplantation.
Chang YJ; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2014 Apr; 20(4):440-9. PubMed ID: 24315844
[TBL] [Abstract][Full Text] [Related]
15. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
Bethge WA; Haegele M; Faul C; Lang P; Schumm M; Bornhauser M; Handgretinger R; Kanz L
Exp Hematol; 2006 Dec; 34(12):1746-52. PubMed ID: 17157172
[TBL] [Abstract][Full Text] [Related]
16. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
[TBL] [Abstract][Full Text] [Related]
17. Optimization of individualized graft composition: CD3/CD19 depletion combined with CD34 selection for haploidentical transplantation.
Huenecke S; Bremm M; Cappel C; Esser R; Quaiser A; Bonig H; Jarisch A; Soerensen J; Klingebiel T; Bader P; Koehl U
Transfusion; 2016 Sep; 56(9):2336-45. PubMed ID: 27346253
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation.
Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR; Mayani H
Ann Hematol; 2006 Feb; 85(2):113-20. PubMed ID: 16311734
[TBL] [Abstract][Full Text] [Related]
19. Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34
Cantilena CR; Ito S; Tian X; Jain P; Chinian F; Anandi P; Keyvanfar K; Draper D; Koklanaris E; Hauffe S; Superata J; Stroncek D; Muranski P; Barrett AJ; Battiwalla M
Biol Blood Marrow Transplant; 2018 Mar; 24(3):460-466. PubMed ID: 29197677
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.
Saad A; Lamb LS
Bone Marrow Transplant; 2017 Sep; 52(9):1241-1248. PubMed ID: 28319073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
